SavedAdd your journal

Journals / Retina-Vitreus / 2017 / Cilt: 26 - Sayı: 2

Intraocular Tuberculosis and Lymphoma Following Immunosuppressive Treatment

İmmünsupresif tedavi Sonrası İntraoküler Tüberküloz ve Lenfoma

M. Necati DEMİR
Gülten SUNGUR
İHSAN GÖKHAN GÜRELİK
Güner ÖZKAN
Berivan BİTİK
Nurten ÜNLÜ
M. Akif ACAR
Pages
169–174
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The tuberculous uveitis and mass lesion of intraocular lymphoma may develop together which may mask the other.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Immunosuppressive treatment carries the risk of serious infection and malignancy.
📊
Key Findings & Data:In this report we aimed to share a seventy-fi ve years old man with rheumatoid arthritis (RA) treated with methotrexate and infl iximab that developed systemic tuberculosis (lung, testicular and eye), primary intraocular and intracranial lymphoma.
💡
Conclusion & Impact:The tuberculous uveitis and mass lesion of intraocular lymphoma may develop together which may mask the other.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Immunosuppressive treatment carries the risk of serious infection and malignancy. In this report we aimed to share a seventy-fi ve years old man with rheumatoid arthritis (RA) treated with methotrexate and infl iximab that developed systemic tuberculosis (lung, testicular and eye), primary intraocular and intracranial lymphoma. The tuberculous uveitis and mass lesion of intraocular lymphoma may develop together which may mask the other.

Özet

İmmunsupresif tedavi ciddi enfeksiyon ve malignensi gelişmesi açısından risk taşımaktadır. Bu olgu sunumunda, Romatoid Artrit (RA) nedeniyle metotreksat ve infl iksimab tedavisi gören 75 yaşında erkek hastada ilerleyen süreçte akciğer, testis ve gözde gelişen sistemik tüberküloz, primer intraoküler ve intrakaraniyal lenfoma patolojileri paylaşılmaktadır. Tüberküloz üveiti ve intraoküler lenfoma kitlesi gözde birlikte gelişebilir ve bunlardan biri diğerini maskeleyebilir.

🔖

Cite This Article

DEMİR, M. N., SUNGUR, G., GÜRELİK, İ. G., ÖZKAN, G., BİTİK, B., ÜNLÜ, N., ACAR, M. A. (2017). Intraocular Tuberculosis and Lymphoma Following Immunosuppressive Treatment. Retina-Vitreus, Cilt: 26 - Sayı: 2, 169–174. https://ajindex.com/articles/304898

References (14)

  1. Murdaca G, Spano F, Contatore M et al. Infection risk associated with anti-TNF-? agents: a review. Expert Opin Drug Saf. 2015
  2. 14(4): 571-82 2. Nordgaard-Lassen I, Dahlerup JF, Belard E et al. Guidlines for screening, prophylaxis and critical information prior to initiating anti-TNF alpha treatment. Dan Med J. 2012
  3. 59(7): C4480 3. Yoo IK, Choung RS, Hyun JJ et al. Incidens of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-? Therapy. 2014
  4. 55(2): 442-448 4. Wang MH, Liu X, Shen B. Disseminated Tuberculosis in a Patient Taking Anti-TNF Therapy for Crohn's Disease. ACG Case Reports Journal. 2015
  5. 3(1): 45-48. 5. Nosotti L, Baiocchini A, Bonifati C et al. Unusal case of B cell lymphoma after immunosuppressive treatment for psoriasis. World Journal of Hepatology. 2015
  6. 7(5): 814-818. 6. Sonoda KH, Fukuhara T, Yoshikawa H et al. A case report of malignant lymphoma receiving infl iximab therapy with Behçet' s disease. Nippon Ganka Gakkai Zasshi. 2014
  7. 118(5):440-445. 7. Quereux G, Renaut JJ, Peuvrel L et al. Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants. Acta Derm Venereol 2010
  8. Mariette X, Tubach F, Bagheri H et al. Lymphoma in patients treated with anti-TNF: results of the 3-year prospectiveFrench RATIO registry. Ann Rheum Dis. 2010
  9. Lin PL, Myers A, Smith L et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 2010
  10. Şenel S, Kılıçkap S. Anti-tümör nekrozis faktör tedavisi ve kanser. Cumhuriyet Tıp Dergisi. 2010
  11. 136 11. Toussirot E, Wendling D. The use of TNF-alpha blocking agents in rheumatoid arthritis: an update. Expert Opin Pharmacother. 2007
  12. 8(13):2089-2107. 12. Bongartz T, Sutton AJ, Sweeting MJ et al. Anti-TNF antibody therapy in rheumatoid arthritis and risk of serious infections and malignancies: sistemic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006
  13. Harigai M, Nanki T, Koike R et al. Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population- a nationwide cohort study in Japan. Mod Rheumatol. 2016
  14. Önal S, Tuğal-Tutkun İ. Oküler Tüberküloz II: Tanı ve Tedavi.